COVID-19

People with COVID-19 are asked to participate in a research study being conducted by the Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are at least ≥18 years of age
• Are positive for SARS-CoV-2 diagnostic test conducted ≤ 5 days prior to randomization
• Have mild or moderate COVID-19 with symptom onset ≤ 5 days before randomization

You may not participate in this study if you:

• Have clinical signs or symptoms indicative of severe or critical COVID-19 illness
• Have admitted to a hospital within 90 days prior to randomization due to COVID-19
• Are likely to experience imminent deterioration and require hospitalization within 24 hours
• Have initiated or planned initiation of remdesivir for treatment of the current COVID-19
• Have an active viral or bacterial infection at the time of screening, such as influenza
• Are receiving dialysis or have known moderate to severe renal impairment
• Have a history of severe hepatic impairment (Child-Pugh Class C)
• Have known allergy or hypersensitivity to components of study drug
• Are pregnant or breast-feeding women

Contact Information
Beendu Pujar, Study Coordinator
Phone: (718) 920-4347
Email: BPUJAR@MONTEFIORE.ORG

23-02-094